Oracle (ORCL) stock's performance has been ordinary, with a downside of 10% in the last 52 weeks. While valuations seem ...

Oracle loses executives health division as several senior leaders depart its health records unit following the Cerner acquisition.

Oracle stock will remain under pressure until it provides tangible evidence that its spending is paying off.

Oracle (ORCL) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

Historical data suggests that ORCL is particularly susceptible to abrupt and steep declines, making it a high-volatility play for investors during periods of ...

Investors continue to fret whether the company has bitten off more than it can chew with its AI-spending commitments.

Oracle shares were up about 3% at $149.45 in early trading. The stock now trades at roughly 19 times projected earnings over ...

Despite Oracle’s underperformance relative to the technology sector over the past year, Wall Street analysts maintain a ...

The company lays out an aggressive new forecast, with a path to nearly quadrupling revenue by fiscal 2030 and a backlog that has already crossed the $500 billion mark Oracle put a key investor concern ...

Oracle is confirmed as a Buy, despite a post-earnings sell-off and near-term volatility. ORCL's cloud segment surged 34% YoY, now its primary growth engine, while legacy software declined 3%. Massive ...

Oracle is set to transform into a top-tier cloud infrastructure player after securing a $300 billion, five-year deal with OpenAI. The "Stargate" project will see ORCL deliver massive AI data center ...

DTE Energy reports better-than-expected quarterly earnings.